Modicare Limited has launched ShiftLife Anti-Spike Daily, a nutraceutical formulation designed to support post-meal glucose and insulin responses. The product features Reducose, a patented white mulberry leaf extract developed by UK-based Phynova, alongside chromium picolinate.
The formulation contains 250 mg of Reducose, a clinically studied ingredient that has demonstrated reductions of up to 40 per cent in post-meal glucose spikes under specific study conditions. It is designed to support metabolic wellness while enabling consumers to maintain their regular dietary preferences.
According to Modicare, ShiftLife Anti-Spike Daily addresses growing consumer interest in glucose wellness, which is increasingly being recognised as an important aspect of overall metabolic health beyond diabetes management.
The product's five highlighted benefits include supporting a moderated post-meal glucose response, helping regulate insulin responses to carbohydrate-rich meals, promoting satiety, addressing sugar cravings and supporting sustained energy. These additional benefits are subject to applicable product-claim substantiation.
The formulation also contains chromium picolinate, which provides chromium, an essential trace mineral involved in normal glucose metabolism. The combination brings together nutritional ingredients intended to support everyday metabolic wellness.
Commenting on the launch, Dr Samir Kumar Modi, Founder and Managing Director, Modicare Limited, said the product aims to encourage greater awareness of metabolic health without requiring consumers to give up traditional foods.
“Food is one of life’s greatest pleasures. It brings families together, creates memories and connects us to our traditions. But taking charge of our health is equally important. For too long, glucose has been a conversation associated mainly with diabetes. Yet metabolic wellness matters to all of us,” he said.
He added that the launch brings clinically researched British nutritional technology to Indian consumers and encourages a broader approach to everyday health.
Wouter Claerhout, Vice President, APAC, Phynova, said the partnership with Modicare would introduce its patented Reducose technology to Indian consumers. He highlighted the ingredient's clinical research on post-meal glucose and insulin responses and its potential role in supporting everyday metabolic wellness.
With the launch, Modicare is targeting the growing interest in preventive nutrition and metabolic health, positioning ShiftLife Anti-Spike Daily as a formulation designed to complement modern Indian dietary habits.